23:36 , Apr 10, 2018 |  BC Extra  |  Preclinical News

Researchers identify coding, non-coding driver mutations in MM

Scientists from the Institute of Cancer Research (London, U.K.) identified coding and non-coding driver mutations involved in newly diagnosed multiple myeloma, suggesting the genes could be targeted to treat the disease. The research was published...
07:00 , Jul 22, 2013 |  BC Week In Review  |  Company News

General Electric sales and marketing update

General Electric's Clarient Diagnostic Services Inc. company launched the Hodgkin Lymphoma Profile by MultiOmyx test to aid in the diagnosis of CD30-positive lymphoma with difficult morphology or otherwise insufficient tissue. The test uses Clarient's MultiOmyx...